944030-47-1

Basic information

• Product Name: (S)-5-phenyl-2-(pyrrolidin-2-yl)-1H-imidazole
• Synonyms: 5-phenyl-2-pyrrolidin-2-yl-1H-imidazole;Y4787;(S)-5-Phenyl-2-(pyrrolidin-2-yl)-1H-imidazole
• CAS NO: 944030-47-1
• Molecular Formula: C13H15N3
• Molecular Weight: 213.282
• Mol File: 944030-47-1.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (S)-5-phenyl-2-(pyrrolidin-2-yl)-1H-imidazole(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-5-phenyl-2-(pyrrolidin-2-yl)-1H-imidazole(944030-47-1)
• EPA Substance Registry System: (S)-5-phenyl-2-(pyrrolidin-2-yl)-1H-imidazole(944030-47-1)

Safety Data

• Hazardous Substances Data: 944030-47-1(Hazardous Substances Data)

Usage

Description

(S)-5-phenyl-2-(pyrrolidin-2-yl)-1H-imidazole is a chiral imidazole derivative with the molecular formula C15H16N2. It features a phenyl group and a pyrrolidin-2-yl group, and the (S)-stereoisomer is recognized as the active form. This chemical compound has been investigated for its potential pharmaceutical applications, which include antifungal and antibacterial properties. Further research is necessary to comprehensively understand its characteristics and possible uses in the medical field.

Uses

Used in Pharmaceutical Industry:
(S)-5-phenyl-2-(pyrrolidin-2-yl)-1H-imidazole is used as an active pharmaceutical ingredient for its potential antifungal and antibacterial properties. Its ability to combat fungal and bacterial infections makes it a promising candidate for the development of new drugs to treat various medical conditions caused by such pathogens.
Used in Research and Development:
In the field of scientific research, (S)-5-phenyl-2-(pyrrolidin-2-yl)-1H-imidazole serves as a valuable compound for studying its chemical properties, stereochemistry, and potential interactions with biological targets. This research can lead to a better understanding of its therapeutic potential and the development of novel treatments for a range of diseases.
Used in Drug Design and Synthesis:
(S)-5-phenyl-2-(pyrrolidin-2-yl)-1H-imidazole is utilized as a key building block in the design and synthesis of new pharmaceutical compounds. Its unique structure and chirality make it an attractive candidate for the creation of novel drugs with improved efficacy, selectivity, and reduced side effects.

Upstream product

• 5468-37-1 2-aminoacetophenone hydrochloride 
• 1148-11-4 N-Benzyloxycarbonyl-L-proline 
• 34079-31-7 Z-Pro-NH₂ 
• 63815-23-6 2-ethoxycarbonimidoyl-pyrrolidine-1-carboxylic acid benzyl ester 
• 63808-36-6 (2S)-2-cyanopyrrolidine-1-carboxylic acid benzyl ester 
• 61350-60-5 (S)-benzyloxycarbonyl-proline acid chloride 
• 15761-39-4 1-(tert-butoxycarbonyl)-L-proline 
• 147-85-3 L-proline 
• 110345-80-7 1-(tert-butyl) 2-(2-oxo-2-phenylethyl) (S)-pyrrolidine-1,2-dicarboxylate 
• 1252037-59-4 (S)-2-(5-phenyl-1H-imidazol-2-yl)-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 944030-46-0 2-(5-phenyl-1H-imidazol-2-yl)-pyrrolidine-1-carboxylic acid benzyl ester 

Downstream Products

• 1350719-28-6 {(S)-2-methyl-1-[(S)-2-(5-phenyl-1H-imidazol-2-yl)pyrrolidine-1-carboline]propyl}carbamic acid methyl ester 
• 1616705-31-7 (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-((S)-2-(5-phenyl-1H-imidazol-2-yl)pyrrolidine-1-carbonyl)icosahydro-1H-cyclopenta[a]chrysen-9-yl acetate 
• 1616704-88-1 2,2-dimethyl-5-oxo-5-(((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-((S)-2-(5-phenyl-1H-imidazol-2-yl)pyrrolidine-1-carbonyl)-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-yl)oxy)pentanoic acid 
• 1616705-51-1 ((1S,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-1-isopropyl-5a,5b,8,8,11a-pentamethylicosahydro-3aH-cyclopenta[a]chrysen-3a-yl)((S)-2-(5-phenyl-1H-imidazol-2-yl)pyrrolidin-1-yl)methanone 
• 1616705-52-2 1-benzyl 3-((1S,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-3a-((S)-2-(5-phenyl-1H-imidazol-2-yl)pyrrolidine-1-carbonyl)icosahydro-1H-cyclopenta[a]chrysen-9-yl)(1R,3S)-2,2-dimethylcyclobutane-1,3-dicarboxylate 
• 1616704-90-5 (1R,3S)-3-((((1S,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-3a-((S)-2-(5-phenyl-1H-imidazol-2-yl)pyrrolidine-1-carbonyl)icosahydro-1H-cyclopenta[a]chrysen-9-yl)oxy)carbonyl)-2,2-dimethylcyclobutane-1-carboxylic acid 
• 1616705-33-9 1-benzyl 3-((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-((S)-2-(5-phenyl-1H-imidazol-2-yl)pyrrolidine-1-carbonyl)-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-yl) (1S,3R)-2,2-dimethylcyclobutane-1,3-dicarboxylate 
• 1616704-81-4 (1S,3R)-2,2-dimethyl-3-((((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-((S)-2-(5-phenyl-1H-imidazol-2-yl)pyrrolidine-1-carbonyl)-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-yl)oxy)carbonyl)cyclobutane-1-carboxylic acid 
• 1616705-25-9 ((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-3a-yl)((S)-2-(5-phenyl-1H-imidazol-2-yl)pyrrolidin-1-yl)methanone 
• 1616704-75-6 2,2-dimethyl-4-oxo-4-((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-((S)-2-(5-phenyl-1H-imidazol-2-yl)pyrrolidine-1-carbonyl)-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-yloxy)butanoic acid 
• 1616704-76-7 3,3-dimethyl-5-oxo-5-((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-((S)-2-(5-phenyl-1H-imidazol-2-yl)pyrrolidine-1-carbonyl)-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-yloxy)pentanoic acid 
• 1616705-32-8 ((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)icosahydro-1H-cyclopenta[a]chrysen-3a-yl)((S)-2-(5-phenyl-1H-imidazol-2-yl)pyrrolidin-1-yl)methanone 
• 1616704-79-0 2,2-dimethyl-4-oxo-4-((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-((S)-2-(5-phenyl-1H-imidazol-2-yl)pyrrolidine-1-carbonyl)icosahydro-1H-cyclopenta[a]chrysen-9-yloxy)butanoic acid 
• 1616704-80-3 3,3-dimethyl-5-oxo-5-((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(1-methylcyclopropyl)-3a-((S)-2-(5-phenyl-1H-imidazol-2-yl)pyrrolidine-1-carbonyl)icosahydro-1H-cyclopenta[a]chrysen-9-yloxy)pentanoic acid 

Relevant articles and documents

Highly efficient organocatalysts for the asymmetric aldol reaction

A new class of bifunctional organocatalysts containing both thiazolidine/pyrrolidine and imidazole cycles was prepared via a readily available synthetic route. The highly efficient five step methodology did not require intermediary purification and provid

NOVEL BETULINIC ACID PROLINE DERIVATIVES AS HIV INHIBITORS

The invention relates to novel betulinic acid derivatives and related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases. These compounds are esterified in position 3 and are substituted in position 17 of the betulinic acid structure, via a linking group W, by a saturated 5-7 membered nitrogen-heterocycle.

PDF INHIBITORS

The invention relates to novel compounds that are inhibitors of peptidyl deformylase (PDF). The compounds are useful as antimicrobials and antibiotics. The compounds of the invention display selective inhibition of peptidyl deformylase versus other metalloproteinases such as MMPs. Methods of preparation and uses of the compounds are also disclosed.